Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies, has appointed Sumant Ramachandra, M.D., Ph.D. as Chief Executive Officer and a member of its Board of Directors. Ramachandra succeeds Co-Founder Noa Shelach, Ph.D., who remains with the company in the newly created position of Chief Operating Officer. About Dr. Ramachandra Ramachandra most recently served as the Founder of SR Global Health, LLC, a healthcare focused advisory Inc. Previo...